LiXia Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
LiXia Zhou has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Kai Zhou
Department of Head and Neck Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China
2 shared publicationsQian Wu
Department of Head and Neck Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China
2 shared publications- Xiaoxia Gou
Head and Neck Oncology, The Second Affiliated Hospital of Zunyi Medical University, China
2 shared publications Hang Yang
Department of Oncology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China
1 shared publicationJieyu Xia
Department of Head and Neck Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China
1 shared publicationXiao Wei
Department of Head and Neck Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China
1 shared publication
Latest Publications
- Open Access
- 9 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Association between alkaline phosphatase and cancer in American adults: 2003–2016 NHANES
While numerous studies have investigated the association between alkaline phosphatase (ALP) levels and the prevalence of cancer, the epidemiological evidence regarding the relationship between ALP and specific cancer types, as well as cancer prognosis, remains inconclusive. This study aimed to fill this gap. This study employed retrospective cohort design utilizing data from the National Health and Nutrition Examination Survey (NHANES) database, covering the period from 2003 to 2016. Mortality data up to December 31, 2017, were retrieved from the National Death Index (NDI). Weighted multivariable logistic regression and restricted cubic spline (RCS) plots were employed to explore nonlinear associations between ALP levels and cancer. Additionally, weighted Cox proportional hazards models and Kaplan-Meier (KM) curves were used to analyze the relationship between ALP levels and all-cause mortality, as well as specific-cause mortality. Subgroup analyses were conducted to assess the consistency of the results. The study included 21,698 participants, with an average age of 47.21 ± 0.27 years, of whom 51.39% were female and 2064 had cancer. Participants were categorized into three models (crude model to model 2) based on different adjustment variables. Fully adjusted weighted logistic regression analysis revealed positive association between ALP levels and higher cancer prevalence (OR: 1.15, 95% CI: 1.00-1.19, P = 0.002). Consistent trend was observed across ALP quartiles (Q4 vs. Q1 OR: 1.42, 95% CI: 1.19–1.70, P for trend < 0.001). The smooth curve fitting model confirmed linear increasing trend between cancer prevalence and ALP levels (P for nonlinearity = 0.390). Further analysis by cancer type indicated that ALP levels were associated with breast cancer (OR: 1.09, 95% CI: 1.05–1.14), digestive system cancers (OR: 1.06, 95% CI: 1.01–1.11), urinary system cancers (OR: 1.05, 95% CI: 1.02–1.08), bone tumors (OR: 1.01, 95% CI: 1.01–1.02), and other cancer types (OR: 1.08, 95% CI: 1.05–1.10). Additionally, the results of multivariable Cox regression analysis showed that the hazard ratio (HR) for all-cause mortality in the Q4 group was 1.81 (95% CI: 1.55–2.12), and the HR for cancer-specific mortality was 1.40 (95% CI: 1.02–1.91). However, no significant trend was observed for cardiovascular mortality (P > 0.05). The KM survival curves for all-cause mortality, cancer-specific mortality, and heart-cause mortality indicated that the mortality rate for individuals in Group Q4 was significantly higher (P log-rank < 0.05). Stratified analysis results showed no significant interaction effects for variables, except for age and LDH (P for interaction > 0.05). Our study indicates that elevated ALP levels are associated with higher prevalence of cancer. Additionally, ALP levels possess significant clinical value in predicting the risks of all-cause and cancer-specific mortality among American adults. Further prospective studies are needed to confirm these results.
- 9 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Open AccessAssociation between alkaline phosphatase and cancer in American adults: 2003–2016 NHANES
While numerous studies have investigated the association between alkaline phosphatase (ALP) levels and the prevalence of cancer, the epidemiological evidence regarding the relationship between ALP and specific cancer types, as well as cancer prognosis, remains inconclusive. This study aimed to fill this gap. This study employed retrospective cohort design utilizing data from the National Health and Nutrition Examination Survey (NHANES) database, covering the period from 2003 to 2016. Mortality data up to December 31, 2017, were retrieved from the National Death Index (NDI). Weighted multivariable logistic regression and restricted cubic spline (RCS) plots were employed to explore nonlinear associations between ALP levels and cancer. Additionally, weighted Cox proportional hazards models and Kaplan-Meier (KM) curves were used to analyze the relationship between ALP levels and all-cause mortality, as well as specific-cause mortality. Subgroup analyses were conducted to assess the consistency of the results. The study included 21,698 participants, with an average age of 47.21 ± 0.27 years, of whom 51.39% were female and 2064 had cancer. Participants were categorized into three models (crude model to model 2) based on different adjustment variables. Fully adjusted weighted logistic regression analysis revealed positive association between ALP levels and higher cancer prevalence (OR: 1.15, 95% CI: 1.00-1.19, P = 0.002). Consistent trend was observed across ALP quartiles (Q4 vs. Q1 OR: 1.42, 95% CI: 1.19–1.70, P for trend < 0.001). The smooth curve fitting model confirmed linear increasing trend between cancer prevalence and ALP levels (P for nonlinearity = 0.390). Further analysis by cancer type indicated that ALP levels were associated with breast cancer (OR: 1.09, 95% CI: 1.05–1.14), digestive system cancers (OR: 1.06, 95% CI: 1.01–1.11), urinary system cancers (OR: 1.05, 95% CI: 1.02–1.08), bone tumors (OR: 1.01, 95% CI: 1.01–1.02), and other cancer types (OR: 1.08, 95% CI: 1.05–1.10). Additionally, the results of multivariable Cox regression analysis showed that the hazard ratio (HR) for all-cause mortality in the Q4 group was 1.81 (95% CI: 1.55–2.12), and the HR for cancer-specific mortality was 1.40 (95% CI: 1.02–1.91). However, no significant trend was observed for cardiovascular mortality (P > 0.05). The KM survival curves for all-cause mortality, cancer-specific mortality, and heart-cause mortality indicated that the mortality rate for individuals in Group Q4 was significantly higher (P log-rank < 0.05). Stratified analysis results showed no significant interaction effects for variables, except for age and LDH (P for interaction > 0.05). Our study indicates that elevated ALP levels are associated with higher prevalence of cancer. Additionally, ALP levels possess significant clinical value in predicting the risks of all-cause and cancer-specific mortality among American adults. Further prospective studies are needed to confirm these results.
- Open Access
- 30 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Associations between dietary nutrient intake and sleep disorders in cancer survivors base on NHANES 2005 to 2018
Sleep disorders significantly impact the quality of life for many individuals, which remain largely unrecognized. It is widely believed that dietary nutrient intake plays a crucial role in promoting healthy sleep patterns. However, there is lack of research focusing on cancer survivors. This study utilized the National Health and Nutrition Examination Survey (NHANES) database to investigate the correlation between dietary nutrient intake and sleep disorders in cancer survivors. Analyzing data from 2882 cancer survivors in NHANES spanning from 2005 to 2018. Dietary nutrient intake was evaluated through two 24-h dietary recalls. Weighted multivariable logistic regression model was employed to further applied to explore the association between dietary fiber intake and sleep disorders while controlling for relevant confounding factors. Additionally, the nonlinear and dose–response relationships were explored using restricted cubic spline (RCS) regression along with smooth curve fitting and threshold effect analysis. Stratified analysis and interaction analysis were conducted to assess the consistency of the results. Univariable and multivariable analysis demonstrated that dietary fiber intake showed negative correlation with sleep disorders (P < 0.05). Treating dietary fiber intake as continuous variable. After accounting for all covariates, the study reaffirmed the protective role of dietary fiber (odds ratio [OR]: 0.99, 95% confidence interval [CI]: 0.98–0.99, P = 0.044). Analysis of dietary fiber intake in quartiles further supported this trend (P < 0.001). Interestingly, further investigations indicated that dietary fiber intake was not associated with sleep apnea, insomnia, restless legs syndrome, or other types of sleep disorders (P > 0.05). Notably, no statistically significant interactions were observed in all subgroup analyses except poverty income ratio (PIR) (P for interaction < 0.05), indicating that the protective effect of dietary fiber on sleep disorders was more pronounced in individuals with PIR ≥ 2.5. Our results suggest that adequate dietary fiber intake may be beneficial dietary strategy to reduce sleep disorders in cancer survivors.
- 30 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Open AccessAssociations between dietary nutrient intake and sleep disorders in cancer survivors base on NHANES 2005 to 2018
Sleep disorders significantly impact the quality of life for many individuals, which remain largely unrecognized. It is widely believed that dietary nutrient intake plays a crucial role in promoting healthy sleep patterns. However, there is lack of research focusing on cancer survivors. This study utilized the National Health and Nutrition Examination Survey (NHANES) database to investigate the correlation between dietary nutrient intake and sleep disorders in cancer survivors. Analyzing data from 2882 cancer survivors in NHANES spanning from 2005 to 2018. Dietary nutrient intake was evaluated through two 24-h dietary recalls. Weighted multivariable logistic regression model was employed to further applied to explore the association between dietary fiber intake and sleep disorders while controlling for relevant confounding factors. Additionally, the nonlinear and dose–response relationships were explored using restricted cubic spline (RCS) regression along with smooth curve fitting and threshold effect analysis. Stratified analysis and interaction analysis were conducted to assess the consistency of the results. Univariable and multivariable analysis demonstrated that dietary fiber intake showed negative correlation with sleep disorders (P < 0.05). Treating dietary fiber intake as continuous variable. After accounting for all covariates, the study reaffirmed the protective role of dietary fiber (odds ratio [OR]: 0.99, 95% confidence interval [CI]: 0.98–0.99, P = 0.044). Analysis of dietary fiber intake in quartiles further supported this trend (P < 0.001). Interestingly, further investigations indicated that dietary fiber intake was not associated with sleep apnea, insomnia, restless legs syndrome, or other types of sleep disorders (P > 0.05). Notably, no statistically significant interactions were observed in all subgroup analyses except poverty income ratio (PIR) (P for interaction < 0.05), indicating that the protective effect of dietary fiber on sleep disorders was more pronounced in individuals with PIR ≥ 2.5. Our results suggest that adequate dietary fiber intake may be beneficial dietary strategy to reduce sleep disorders in cancer survivors.